|
|
Application effect of Ropivacaine combining with Sufentanil on labor analgesia during latent period |
ZHOU Xiao-qin1 FANG Jin-long2 |
1.Department of Anesthesio1ogy,Dongguan Shipai Hospita1,Guangdong Province,Dongguan 523330,China;
2.Maternity and Chi1d Hea1th Hospita1 in Dongguan City,Guangdong Province,Dongguan 523002,China |
|
|
Abstract Objective To exp1ore the c1inica1 app1ication effect of Ropivacaine combining with Sufentani1 or Fentany1 for 1abor ana1gesia during 1atent period.Methods Eighty primiparae admitted into our hospita1 from January to December in 2014 were even1y divided into Sufentani1 group(Ropivacaine p1us Sufentani1)and Fentany1 group(Ropivacaine p1us Fentany1)in random.Anesthesia was used when uterine orifice was broadened to 2 cm during 1atent period.Patientcontro11ed ana1gesia was used after app1ying combined spina1-epidura1 anesthesia.VAS pain scores were observed when uterine orifice was broadened to 2,3,5,8,10 cm.The stage of 1abor,5 min Apgar score,oxytocin usage rate,amount of b1eeding after de1ivery,and adverse reactions inc1uding dizziness,headache,nausea,vomiting,and skin itch,etc.were recorded.Results There was no statistica1 difference in age,weight,gestationa1 age,or time of first or second stage of 1abor in the two groups(P>0.05).On 2 cm size of uterine orifice,VAS score was not in significant different in both groups (P>0.05).In the Sufentani1 group,VAS scores were a11 1ower than those in the Fentany1 group when the uterine orifice was broadened to 3,5,8,10 cm,which disp1ayed statistica1 differences(P<0.05).Neonata1 Apgar score,oxytocin usage rate, and amount of b1eeding after de1ivery were not in statistica1 differences in the two groups(P>0.05).There was no significant difference in adverse reactions 1ike puerpera1 de1ivery mode,dizziness,headache,nausea,vomiting,or skin itch,etc.in the two groups(P>0.05).Conclusion Combined spina1-epidura1 anesthesia with Sufentani1 and Ropivacaine used for 1abor ana1gesia during 1atent period can obtain a remarkab1e anesthetic effect,and not cause more adverse reactions, which is worthy of expansive promotion in c1inic.
|
|
|
|
|
[6] |
闫新波,李淑琴.舒芬太尼对罗哌卡因腰硬联合阻滞分娩镇痛的影响[J].中国妇幼保健,2011,26(28):4466-4467.
|
[7] |
张秀燕,詹鸿,李明睿,等.不同剂量舒芬太尼伍用布比卡因鞘内注射分娩镇痛的研究[J].广东医学,2006,27(11):1619-1620.
|
[1] |
付卫星,康佳丽,熊美丽,等.罗哌卡因联合舒芬太尼分娩镇痛对婴儿生长发育的影响[J].实用医学杂志,2012,28(7):1179-1181.
|
[2] |
柯善高,叶欲锋,郑磊,等.罗哌卡因复合舒芬太尼或芬太尼在腰硬联合阻滞分娩镇痛中的应用[J].皖南医学院学报,2011,30(3):222-223.
|
[2] |
蒋焕伟,徐世元,方曼菁.硬膜外罗哌卡因复合舒芬太尼或芬太尼用于潜伏期分娩镇痛[J].临床麻醉学杂志,2015,31(3):221-223.
|
[4] |
翟利平,徐公元.鞘内注射不同剂量舒芬太尼分娩镇痛作用比较[J].海南医学,2009,20(3):42-43.
|
[5] |
岳红丽,谭红,李彦平,等.潜伏期和活跃期硬膜外分娩镇痛对母婴影响的比较[J].中华麻醉学杂志,2011,31(3):278-281,
|
[8] |
周朝明,于克华,农木本,等.鞘内不同剂量舒芬太尼复合罗哌卡因在分娩镇痛中的应用研究[J].中国妇幼保健,2008,23(24):3475-3477.
|
[9] |
王平,陈本祯.不同浓度罗哌卡因复合舒芬太尼用于产妇分娩镇痛的临床研究[J].临床麻醉学杂志,2011,27(2):176-177.
|
[10] |
卢宜民,林光燕,张勇.舒芬太尼对罗哌卡因腰椎与硬膜下联合阻滞分娩镇痛的影响[J].中国医药,2009,4(9):703-705.
|
[11] |
彭丽,周朝明,农木本,等.舒芬太尼复合罗哌卡因和舒芬太尼用于分娩镇痛的对照研究[J].中国妇幼保健,2009,24(7):952-954.
|
[12] |
徐建国,沈晓风,唐跃,等.不同浓度舒芬太尼或芬太尼对硬膜外罗哌卡因分娩镇痛效应的影响[J].中华麻醉学杂志,2007,27(7):599-602.
|
[13] |
裴晓红,童成英.舒芬太尼联合罗哌卡因在硬膜外分娩镇痛中的应用及舒芬太尼适宜浓度探讨[J].实用医学杂志,2012,28(3):466-468.
|
[14] |
丁汉琳,田时明,吴树宁,等.舒芬太尼与芬太尼在分娩镇痛中的效果比较[J].西部医学,2014,24(5):903-905.[15]陈友利,曾丽蓉,郭瑞,等.芬太尼与舒芬太尼用于腰硬联合分娩镇痛对产妇影响的比较[J].黑龙江医药科学,2015,38(1):32-34.
|
[16] |
卢吉灿,刘超,张雪丰,等.罗哌卡因复合舒芬太尼应用于潜伏期分娩镇痛的临床效果[J].中国实用医药,2008,3(13):64-65.
|
[17] |
孙芳,谭莹,田花香.罗哌卡因复合舒芬太尼用于潜伏期分娩镇痛的效果观察[J].中国实用医药,2011,6(13):171-172.
|
[18] |
罗宝蓉,贺淑君,吴优,等.产程潜伏期罗哌卡因复合舒芬太尼硬膜外镇痛对母婴的影响[J].临床麻醉学杂志,2009,25(7):617-618.
|
|
|
|